Brines M - Search Results

1

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.

Lois N, Gardner E, McFarland M, Armstrong D, McNally C, Lavery NJ, Campbell C, Kirk RI, Bajorunas D, Dunne A, Cerami A, Brines M. Lois N, et al. Among authors: brines m. J Clin Med. 2020 Jul 14;9(7):2225. doi: 10.3390/jcm9072225. J Clin Med. 2020. PMID: 32674280 Free PMC article.

2

Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain.

Culver DA, Dahan A, Bajorunas D, Jeziorska M, van Velzen M, Aarts LPHJ, Tavee J, Tannemaat MR, Dunne AN, Kirk RI, Petropoulos IN, Cerami A, Malik RA, Brines M. Culver DA, et al. Among authors: brines m. Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO52-BIO60. doi: 10.1167/iovs.16-21291. Invest Ophthalmol Vis Sci. 2017. PMID: 28475703 Clinical Trial.

3

Erythropoietin and engineered innate repair activators.

Brines M, Cerami A. Brines M, et al. Methods Mol Biol. 2013;982:1-11. doi: 10.1007/978-1-62703-308-4_1. Methods Mol Biol. 2013. PMID: 23456859

4

ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes.

Brines M, Dunne AN, van Velzen M, Proto PL, Ostenson CG, Kirk RI, Petropoulos IN, Javed S, Malik RA, Cerami A, Dahan A. Brines M, et al. Mol Med. 2015 Mar 13;20(1):658-66. doi: 10.2119/molmed.2014.00215. Mol Med. 2015. PMID: 25387363 Free PMC article. Clinical Trial.

5

The receptor that tames the innate immune response.

Brines M, Cerami A. Brines M, et al. Mol Med. 2012 May 9;18(1):486-96. doi: 10.2119/molmed.2011.00414. Mol Med. 2012. PMID: 22183892 Free PMC article. Review.

6

Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.

Brines M, Cerami A. Brines M, et al. J Intern Med. 2008 Nov;264(5):405-32. doi: 10.1111/j.1365-2796.2008.02024.x. J Intern Med. 2008. PMID: 19017170 Free article. Review.

7

Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand.

Yao M, Watanabe M, Sun S, Tokodai K, Cerami A, Brines M, Östenson CG, Ericzon BG, Lundgren T, Kumagai-Braesch M. Yao M, et al. Among authors: brines m. Transplantation. 2020 Oct;104(10):2048-2058. doi: 10.1097/TP.0000000000003284. Transplantation. 2020. PMID: 32345869

8

Corneal confocal microscopy: ready for prime time.

Petropoulos IN, Ponirakis G, Khan A, Gad H, Almuhannadi H, Brines M, Cerami A, Malik RA. Petropoulos IN, et al. Among authors: brines m. Clin Exp Optom. 2020 May;103(3):265-277. doi: 10.1111/cxo.12887. Epub 2019 Mar 4. Clin Exp Optom. 2020. PMID: 30834591 Free article. Review.

9

The vasoreparative potential of endothelial colony-forming cells in the ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimetic.

O'Leary OE, Canning P, Reid E, Bertelli PM, McKeown S, Brines M, Cerami A, Du X, Xu H, Chen M, Dutton L, Brazil DP, Medina RJ, Stitt AW. O'Leary OE, et al. Among authors: brines m. Exp Eye Res. 2019 May;182:144-155. doi: 10.1016/j.exer.2019.03.001. Epub 2019 Mar 12. Exp Eye Res. 2019. PMID: 30876881

10

Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation.

Yao M, Domogatskaya A, Ågren N, Watanabe M, Tokodai K, Brines M, Cerami A, Ericzon BG, Kumagai-Braesch M, Lundgren T. Yao M, et al. Among authors: brines m. Cell Transplant. 2021 Jan-Dec;30:9636897211039739. doi: 10.1177/09636897211039739. Cell Transplant. 2021. PMID: 34498509 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters